BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6198560)

  • 1. Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins.
    Vogel AM; Gown AM; Caughlan J; Haas JE; Beckwith JB
    Lab Invest; 1984 Feb; 50(2):232-8. PubMed ID: 6198560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross-reacting antibodies.
    Gown AM; Vogel AM
    J Cell Biol; 1982 Nov; 95(2 Pt 1):414-24. PubMed ID: 6183272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
    Banks-Schlegel SP; Gazdar AF; Harris CC
    Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins.
    Holthöfer H; Miettinen A; Paasivuo R; Lehto VP; Linder E; Alfthan O; Virtanen I
    Lab Invest; 1983 Sep; 49(3):317-26. PubMed ID: 6193332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys.
    Holthöfer H; Miettinen A; Lehto VP; Lehtonen E; Virtanen I
    Lab Invest; 1984 May; 50(5):552-9. PubMed ID: 6201675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture.
    LaRocca PJ; Rheinwald JG
    Cancer Res; 1984 Jul; 44(7):2991-9. PubMed ID: 6202404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of monoclonal antibodies to intermediate filament proteins in surgical pathology of head and neck tumours. An overview.
    Ramaekers FC
    Appl Pathol; 1988; 6(1):35-48. PubMed ID: 2451926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
    Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
    Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate filament typing of tumor cells in fine needle aspirates by means of monoclonal antibodies.
    Domagala W; Lubinski J; Weber K; Osborn M
    Acta Cytol; 1986; 30(3):214-24. PubMed ID: 2424205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.
    Ramaekers F; Huysmans A; Moesker O; Kant A; Jap P; Herman C; Vooijs P
    Lab Invest; 1983 Sep; 49(3):353-61. PubMed ID: 6193333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate filament proteins in choroid plexus and ependyma and their tumors.
    Miettinen M; Clark R; Virtanen I
    Am J Pathol; 1986 May; 123(2):231-40. PubMed ID: 2422943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies specific for vimentin.
    Osborn M; Debus E; Weber K
    Eur J Cell Biol; 1984 May; 34(1):137-43. PubMed ID: 6428888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between tektins and intermediate filament proteins: an immunological study.
    Steffen W; Linck RW
    Cell Motil Cytoskeleton; 1989; 14(3):359-71. PubMed ID: 2582496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mammalian synemin, an intermediate filament protein present in all four classes of muscle cells and some neuroglial cells: co-localization and interaction with type III intermediate filament proteins and keratins.
    Hirako Y; Yamakawa H; Tsujimura Y; Nishizawa Y; Okumura M; Usukura J; Matsumoto H; Jackson KW; Owaribe K; Ohara O
    Cell Tissue Res; 2003 Aug; 313(2):195-207. PubMed ID: 12845519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to intermediate filament proteins as molecular markers in clinical tumor pathology. Differentiation of carcinomas by their reaction with different cytokeratin antibodies.
    Krepler R; Denk H; Artlieb U; Fichtinger E; Davidovits A
    Pathol Res Pract; 1982; 175(2-3):212-26. PubMed ID: 6190145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human sarcomatous Wilms' tumor lines: evidence for epithelial differentiation in clear cell sarcoma of the kidney.
    Ishii E; Fujimoto J; Hara S; Tanaka S; Hata J
    Cancer Res; 1989 Oct; 49(19):5392-9. PubMed ID: 2475248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteins of intermediate filaments. An immunohistochemical and biochemical approach to the classification of soft tissue tumors.
    Denk H; Krepler R; Artlieb U; Gabbiani G; Rungger-Brändle E; Leoncini P; Franke WW
    Am J Pathol; 1983 Feb; 110(2):193-208. PubMed ID: 6824065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intermediate filament complement of the spectrum of nerve sheath neoplasms.
    Gould VE; Moll R; Moll I; Lee I; Schwechheimer K; Franke WW
    Lab Invest; 1986 Oct; 55(4):463-74. PubMed ID: 3531717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of microtubules and intermediate filaments in maintaining the shape of epithelial cells].
    Karavanova ID; Vasil'ev IuM; Troianovskiĭ SM
    Tsitologiia; 1985 Jun; 27(6):693-7. PubMed ID: 2411035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to different intermediate filaments as histogenetic tumormarkers.
    Schauer A; Osborn M; Weber K; Altmannsberger M
    Acta Histochem Suppl; 1984; 29():129-36. PubMed ID: 6201951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.